SFDA approves Qfitlia for bleeding prevention in hemophilia patients

Saudi Gazette reportRIYADH — The Saudi Food and Drug Authority (SFDA) has approved Qfitlia (Fitusiran) for the prevention or reduction of bleeding episodes in adults and adolescents aged 12 and above